|
|
|
Catalyst Bio 
|
6.165 -0.095 (-0.02%) |
03-04 10:31 |
Open: |
6.19 |
Pre close: |
6.26 |
Target:
|
7.91
|
High: |
6.4 |
Low: |
5.98 |
Resistance:
|
6.77
7.55
|
Volume: |
129,199 |
Market Cap: |
190M |
Support:
|
5.52
4.59
|
|
|
|
Technical Analysis |
Moving Averages |
MA(5):
|
6.20
 |
MACD |
MACD(12,26):
|
-0.03  |
MA(20): |
6.37  |
Signal(12,26,9): |
-0.00  |
MA(100): |
6.07  |
Stochastic Oscillator |
%K(14,3):
|
28.96  |
MA(250): |
5.74  |
%D(3): |
26.69  |
Average Volume(K) |
3-Month: |
47893
|
52-Week |
High:
|
8.22 |
10-Days: |
35245 |
Low: |
3.43 |
RSI |
RSI(14):
|
51.37  |
Change(%): |
11.8 |
Financials, Statistics and Valuation |
EPS |
-3.060 |
Return on Equity (ttm) |
-58.1 |
Shares Out. (M) |
22.10 |
EPS Est. Current Year |
-7.910 |
Return on Assets (ttm) |
-31.8 |
Shares Float (M) |
17.84 |
EPS Est. Next Year |
-4.810 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.55 |
EPS Est. Next Quarter |
-1.550 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
64.58 |
Forward EPS |
-2.680 |
Gross Profit (p.s.) |
-1.985 |
Shares Short (K) |
586 |
Book Value (p.s.) |
4.260 |
EBITDA (p.s.) |
-2.334 |
P/E |
-2.08 |
Sales Per Share |
0.856 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.50 |
Profit Margin |
-269.30 |
Operating Cash Flow
(M) |
-41.02 |
P/S |
7.44 |
Operating Margin |
-273.38 |
Levered Free Cash Flow
(M) |
-22.25 |
P/CF |
-3.43 |
|
|
|
|
|